To ensure transparency, the Management Board shall, on the basis of a proposal by the Executive Director and in agreement with the Commission, adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the safety of substances on their own, in preparations or in articles which is not of a confidential nature.
◷
New version applies from 20/01/2009 — introduced by CLP Regulation.
111 provisions change.
Later versions: 20/02/2009, 27/06/2009, 02/04/2010, 01/12/2010, 21/02/2011, 06/03/2011, 05/05/2011, 10/12/2011, 01/06/2012, 05/06/2012, 09/10/2012, 06/03/2013, 21/04/2013, 01/07/2013, 10/04/2014, 22/08/2014, 01/01/2015, 23/03/2015, 13/05/2015, 01/06/2015, 25/09/2015, 27/12/2015, 03/02/2016, 08/03/2016, 01/04/2016, 21/06/2016, 14/07/2016, 11/10/2016, 02/01/2017, 02/03/2017, 04/07/2017, 10/10/2017, 31/01/2018, 01/03/2018, 09/05/2018, 01/12/2018, 07/01/2019, 02/07/2019, 30/10/2019, 01/01/2020, 27/02/2020, 28/04/2020, 24/08/2020, 01/01/2021, 15/02/2021, 05/07/2021, 25/08/2021, 01/10/2021, 08/01/2022, 01/03/2022, 01/05/2022, 14/10/2022, 17/12/2022, 28/05/2023, 29/06/2023, 06/08/2023, 01/12/2023, 06/06/2024, 10/10/2024, 22/04/2025, 23/06/2025, 01/09/2025, 23/10/2025, 11/05/2026, 22/06/2026.
Article 109 changes in this version: compare with the current text.